Abstract
The criteria for the diagnosis of the atypical facial neuralgia make it is possible to classify under this neurological diagnosis also psychiatric disorders as conasthetic depression. In two case reports it is told about patients with both diagnosis. Due to this they were treated with an atypical neurolepticum (Olanzapine) to reach three targets: Therapy of the depression, pain i.e. atypical facial neuralgia and mood stabilizing. Within the last four years there were no side-effects as EPMS to observe.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
